These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 7679844)

  • 1. Human mouse chimeric CD7 monoclonal antibody (SDZCHH380) for the prophylaxis of kidney transplant rejection.
    Lazarovits AI; Rochon J; Banks L; Hollomby DJ; Muirhead N; Jevnikar AM; White MJ; Amlot PL; Beauregard-Zollinger L; Stiller CR
    Transplant Proc; 1993 Feb; 25(1 Pt 1):820-2. PubMed ID: 7679844
    [No Abstract]   [Full Text] [Related]  

  • 2. Human mouse chimeric CD7 monoclonal antibody (SDZCHH380) for the prophylaxis of kidney transplant rejection.
    Lazarovits AI; Rochon J; Banks L; Hollomby DJ; Muirhead N; Jevnikar AM; White MJ; Amlot PL; Beauregard-Zollinger L; Stiller CR
    J Immunol; 1993 Jun; 150(11):5163-74. PubMed ID: 7684422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human mouse chimeric CD7 monoclonal antibody (SDZCHH380) for the prophylaxis of kidney transplant rejection: analysis beyond 4 years.
    Sharma LC; Muirhead N; Lazarovits AI
    Transplant Proc; 1997; 29(1-2):323-4. PubMed ID: 9123021
    [No Abstract]   [Full Text] [Related]  

  • 4. [The immunobiology of transplant rejection and its pharmacological modification].
    Köhler H; Zanker B; Strom TB
    Dtsch Med Wochenschr; 1991 Feb; 116(7):264-9. PubMed ID: 1825196
    [No Abstract]   [Full Text] [Related]  

  • 5. OKT3 prophylaxis in kidney transplant recipients: drug monitoring by flow cytometry.
    Cinti P; Cocciolo P; Evangelista B; Orlandini AM; Bruzzone P; Renna Molajoni E; Cortesini R
    Transplant Proc; 1996 Dec; 28(6):3214-6. PubMed ID: 8962245
    [No Abstract]   [Full Text] [Related]  

  • 6. The clinical application of monoclonal antibody therapies in renal transplantation.
    Dhanireddy KK; Xu H; Mannon RB; Hale DA; Kirk AD
    Expert Opin Emerg Drugs; 2004 May; 9(1):23-37. PubMed ID: 15155134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refractory acute kidney transplant rejection with CD20 graft infiltrates and successful therapy with rituximab.
    Alausa M; Almagro U; Siddiqi N; Zuiderweg R; Medipalli R; Hariharan S
    Clin Transplant; 2005 Feb; 19(1):137-40. PubMed ID: 15659147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive drugs for kidney transplantation.
    Halloran PF
    N Engl J Med; 2004 Dec; 351(26):2715-29. PubMed ID: 15616206
    [No Abstract]   [Full Text] [Related]  

  • 9. Chimeric CD7 monoclonal antibody therapy in rheumatoid arthritis.
    Kirkham BW; Thien F; Pelton BK; Pitzalis C; Amlot P; Denman AM; Panayi GS
    J Rheumatol; 1992 Sep; 19(9):1348-52. PubMed ID: 1279168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into therapy with monoclonal antibodies in allograft transplantation.
    Schena FP
    Nephrol Dial Transplant; 1997; 12 Suppl 1():55-8. PubMed ID: 9075230
    [No Abstract]   [Full Text] [Related]  

  • 11. Expansion of CD4+CD7- T helper cells with a TH0-TH2 function in kidney transplant recipients.
    Barrou B; Legac E; Blanc C; Bitker MO; Luciani J; Chatelain C; Debré P; Autran B
    Transplant Proc; 1995 Apr; 27(2):1676-7. PubMed ID: 7536977
    [No Abstract]   [Full Text] [Related]  

  • 12. The utility of monoclonal antibody therapy in renal transplantation.
    Loertscher R
    Transplant Proc; 2002 May; 34(3):797-800. PubMed ID: 12034186
    [No Abstract]   [Full Text] [Related]  

  • 13. Review and preview of anti-T-cell antibodies.
    Helderman JH
    Transplant Proc; 1995 Oct; 27(5 Suppl 1):8-9. PubMed ID: 7482824
    [No Abstract]   [Full Text] [Related]  

  • 14. Selection and chimerization of a monoclonal CD4 antibody for heart transplantation.
    Reiter C; Meiser BM; Uberfuhr P; Wenke K; Reichenspurner H; Kreuzer E; Rieber EP; Riethmüller G; Reichart B
    Transplant Proc; 1993 Feb; 25(1 Pt 1):788-9. PubMed ID: 8438481
    [No Abstract]   [Full Text] [Related]  

  • 15. Monoclonal antibodies in organ transplantation.
    Valdés RH
    Transplant Proc; 1996 Dec; 28(6):3293. PubMed ID: 8962277
    [No Abstract]   [Full Text] [Related]  

  • 16. Peripheral blood monitoring during and after rejection-prophylaxis with a monoclonal anti-interleukin-2-receptor antibody in kidney and heart transplant recipients.
    van Gelder T; Knoop CJ; Hesse CJ; Vaessen LM; Balk AH; Yzermans JN; Weimar W
    Transplant Proc; 1995 Feb; 27(1):856-8. PubMed ID: 7879206
    [No Abstract]   [Full Text] [Related]  

  • 17. In situ antigenic modulation of human graft-infiltrating T cells is induced by OKT3 treatment.
    Caillat-Zucman S; Legendre C; Noel LH; Bach JF; Kreis H; Chatenoud L
    Transplant Proc; 1990 Aug; 22(4):1782. PubMed ID: 2143860
    [No Abstract]   [Full Text] [Related]  

  • 18. Prophylactic use of the anti-IL-2 receptor monoclonal antibody LO-Tact-1 in cadaveric renal transplantation: results of a randomized study.
    Kriaa F; Hiesse C; Alard P; Lantz O; Noury J; Charpentier B; Bazin H
    Transplant Proc; 1993 Feb; 25(1 Pt 1):817-9. PubMed ID: 8438496
    [No Abstract]   [Full Text] [Related]  

  • 19. The potential role of therapeutic antibodies in the regulation of rejection.
    Ettenger RB; Yadin O
    Transplant Proc; 1995 Oct; 27(5 Suppl 1):13-7. PubMed ID: 7482810
    [No Abstract]   [Full Text] [Related]  

  • 20. Humoral immune response against OKT3.
    Chatenoud L
    Transplant Proc; 1993 Apr; 25(2 Suppl 1):68-73. PubMed ID: 8465430
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.